Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
November 18, 2022 at 10:52 AM EST
Pfizer and BioNTech said the immune response generated by their bivalent COVID-19 booster showed strong results against the newer omicron sublineages.